Biotechnology · Health Care
Adaptive Biotech: Funding & valuation
Adaptive Biotech: 2 money records, each linked to its source.
Data updated Nov 20, 2026 · Back to the company report
Financials
Revenue of $277M in 2025. +54.8% on the year before. Net income −$59.5M.
$277MRevenue2025 · +54.8%
−$59.5MNet income2025 · +62.7%
Revenue by yearas filed, with the net income
Sources: SEC
Money
Adaptive Biotech: 2 money records, each linked to its source.
$3MCapital expenditureFY2025
From its filingssec.gov ↗
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Capital expenditure | $10.7M | $3.7M | $3M |
| Stock-based compensation | $62.9M | $53.6M | $51.5M |
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
